Home Deuterated Building Blocks 154447-35-5
154447-35-5,MFCD06798345
Catalog No.:AA00AQ8V

154447-35-5 | 2-(Morpholin-4-yl)benzo[h]chromen-4-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98+%
in stock  
$28.00   $20.00
- +
5mg
98+%
in stock  
$82.00   $57.00
- +
50mg
≥98%
in stock  
$802.00   $562.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00AQ8V
Chemical Name:
2-(Morpholin-4-yl)benzo[h]chromen-4-one
CAS Number:
154447-35-5
Molecular Formula:
C17H15NO3
Molecular Weight:
281.3059
MDL Number:
MFCD06798345
SMILES:
O=c1cc(oc2c1ccc1c2cccc1)N1CCOCC1
Properties
Computed Properties
 
Complexity:
441  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
4  
Rotatable Bond Count:
1  
XLogP3:
2.8  

Literature

Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

Journal: The Biochemical journal 20130415

Title: Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signaling.

Journal: Toxicology 20120904

Title: Regulation of DNA damage response and cell cycle in radiation-resistant HL60 myeloid leukemia cells.

Journal: Oncology reports 20120701

Title: Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells.

Journal: Investigational new drugs 20120601

Title: DNA double-strand breaks induced by cavitational mechanical effects of ultrasound in cancer cell lines.

Journal: PloS one 20120101

Title: Identification of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) as a novel target of bisphenol A.

Journal: PloS one 20120101

Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.

Journal: Nature biotechnology 20111101

Title: Synthesis, structural elucidation, DNA-PK inhibition, homology modelling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines.

Journal: Bioorganic & medicinal chemistry 20110701

Title: A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia.

Journal: Journal of cell science 20110601

Title: Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents.

Journal: Journal of medicinal chemistry 20110414

Title: Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR.

Journal: Nature chemical biology 20110413

Title: Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs.

Journal: PloS one 20110101

Title: DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.

Journal: Journal of medicinal chemistry 20101223

Title: DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.

Journal: Experimental oncology 20101201

Title: DNA-PK promotes the survival of young neurons in the embryonic mouse retina.

Journal: Cell death and differentiation 20101101

Title: Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}.

Journal: Cancer research 20101101

Title: Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs.

Journal: Aging 20101001

Title: Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer.

Journal: Science translational medicine 20100908

Title: DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells.

Journal: Free radical biology & medicine 20100515

Title: Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt.

Journal: Cellular signalling 20100101

Title: ATM is the predominant kinase involved in the phosphorylation of histone H2AX after heating.

Journal: Journal of radiation research 20100101

Title: Impaired NHEJ function in multiple myeloma.

Journal: Mutation research 20090115

Title: Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.

Journal: The Journal of biological chemistry 20080418

Title: A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20071218

Title: Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.

Journal: The Journal of pharmacology and experimental therapeutics 20070601

Title: Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma a549 cells.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20060501

Title: DNA end joining activity is reduced in Alzheimer's disease.

Journal: Neurobiology of aging 20060401

Title: Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.

Journal: Nucleic acids research 20060101

Title: Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach.

Journal: Journal of medicinal chemistry 20051201

Title: Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026.

Journal: British journal of cancer 20051031

Title: Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway.

Journal: Blood 20050615

Title: Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro.

Journal: Journal of medicinal chemistry 20050127

Title: Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries.

Journal: Bioorganic & medicinal chemistry letters 20041220

Title: Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair.

Journal: Oncogene 20040923

Title: A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.

Journal: Blood 20040615

Title: 2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK).

Journal: Bioorganic & medicinal chemistry letters 20030915

Title: Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.

Journal: Cancer research 20030915

Title: LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family.

Journal: Bioorganic & medicinal chemistry letters 20010409

Title: The DNA-dependent protein kinase.

Journal: Genes & development 19990415

Title: Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 19970701

Title: Differential implications of the oncogene-tumor suppressor gene complex in the geneses of 19 human neoplasias. Evidence in support of the steroid carcinogenesis hypothesis.

Journal: Anticancer research 19970101

Title: Veuger SJ, et al. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res. 2003 Sep 15;63(18):6008-15.

Title: Amrein L, et al. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[hchomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase. J

Title: Nutley BP, et al. Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026. Br J Cancer. 2005 Oct 31;93(9):1011-8.

Title: Ciszewski WM, et al. Interleukin-4 enhances PARP-dependent DNA repair activity in vitro. J Interferon Cytokine Res. 2014 Sep;34(9):734-40.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 154447-35-5
Tags:154447-35-5 Molecular Formula|154447-35-5 MDL|154447-35-5 SMILES|154447-35-5 2-(Morpholin-4-yl)benzo[h]chromen-4-one